Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Allergic Rhinitis and Conjunctivitis
When do you consider lifelong AIT?
Related Questions
Do you consider the efficacy of different nasal sprays when prescribing for allergic rhinitis or conjunctivitis?
When should we suspect ‘climate-amplified’ rhinitis/asthma versus poor control from other causes?
Are there best practices for integrating pollen, wildfire smoke, and AQI data into asthma/allergic rhinitis action plans?
Is there a specific group of children that you start on AIT for prevention of asthma?
When initiating patients on Ragwitek, Odactra, and Grastek and the plan is to continue on all 3 tablets for the next 5 years instead of only for seasons, how far apart from each one do you give the initial dose?
How do you address the discrepancy between traditional allergy skin testing and the Rinkel skin test results?
How are you using SLIT if that is the method you use to treat allergic rhinits?
For adult patients on montelukast who experience vivid dreams intermittently but no other psychiatric/neuro side effects, do you permanently discontinue the medication for dreams alone or do you still have patients take it PRN if it is significantly helping to control their other allergic symptoms?
Would you consider levofloxacin graded challenge, extended IV aztreonam, or an alternative treatment in a patient with reported anaphylaxis to penicillin, fluoroquinolones, and cefuroxime with cavitary pneumonia secondary to Klebsiella and Pseudomonas?
How would you approach diagnosis of a patient with recurrent episodes of abdominal pain, severe myalgias, low grade fevers and urticaria?
